Introducing the results related to the programs that AMED's supports R&D
Achievements
What's New
-
2020.3.24Hypertension and obesity were identified as major risk factors for shortening the life spans of today using genomic information collected from 700,000 people - Elucidation of health factors, treatable in all people, using inherent genetic information -
-
2020.3.23Identification of an existing Japanese pancreatitis drug, Nafamostat, as a candidate drug to prevent transmission of SARS-CoV-2
-
2020.3.23Involvement of the gene responsible for lysosomal disease in the development of Parkinson's disease - Possibility of a novel therapy targeting a lysosomal-related protein -
-
2020.3.19Identification of an intracellular signal critical for the development of head and neck cancer - Creation of a mouse model for the fastest cancer development -
-
2020.3.16Start of operation of a pathological diagnosis network and verification of an AI diagnosis system
-
2020.3.13Identification of the gene responsible for progressive myoclonic epilepsy
-
2020.3.12World's first prospective clinical test on a rare type of malignant lymphoma - Establishment of a standard treatment to improve the prognosis of patients -
-
2020.3.7Establishment of a foundation for the simulation experiment of bone reconstruction (remodeling) - To predict the effects of drug therapy on bone diseases -
-
2020.3.6Elucidation of the mechanism of psychosomatic correlation connecting the mind and body - A new treatment strategy for stress-related diseases -
-
2020.3.6Characterization of mitochondria carrying unique genomes in a Japanese population